Evidence map›Paper›PMID 39669140›Full record

ArticleHeliyon2024

Heart disease prediction using ECG-based lightweight system in IoT based on meta-heuristic approach.

Amin Abbaszadeh, Mahdi Bazargani

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Amin AbbaszadehDepartment of Computer Engineering, Zanjan Branch, Islamic Azad University, Zanjan, Iran.
Mahdi BazarganiDepartment of Computer Engineering, Zanjan Branch, Islamic Azad University, Zanjan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Annually, the proportion of individuals suffering from cardiovascular disease rises significantly. Heart attacks are the most prevalent and unpleasant illness among them. Heart disease (HD) diagnosis can be complicated when there are multiple symptoms. The growing popularity of wearable smart devices has increased the likelihood of providing the Internet of Things (IoT). However, one of the biggest obstacles to overcome in implementing the system under IoT is developing a lightweight model for cardiac diagnosis and categorization. In this paper, we have presented a two-step heart disease classification method. This method includes demarcation of classes with the help of optimized non-linear support vector machine technique in the first step and determining the modified fuzzy class in the second step. Initially, pre-processing is accomplished using the ECG signals to eliminate noise and improve signal smoothness. Subsequently, features such as PQRS wave, linear characteristics, and reciprocal information are extracted from pre-processed signals. At the classification stage, the two-stage learning system is used to classify cardiac arrhythmias. First, using the wild horse optimization (WHO) technique (WHO-sigmoid-TH-NL-demarcation), each class is subjected to a binary classification based on feature demarcation, thresholding, and weighting of the sigmoid function. The information from the first stage will be transferred into the subsequent stage for an equal number of heart disease classifications. In the second step, a TS fuzzy logic system optimized by the Giza Pyramids Construction (GPC) approach (GPC-TS-Fuzzy) is utilized to classify each signal. The MIT-BIH arrhythmia dataset is used to assess the suggested approach. In a comprehensive evaluation of the suggested method, performance metrics including "accuracy, sensitivity, and specificity" yielded average values of 98.58 %, 98.13 %, and 96.47 %, respectively. The MATLAB platform is utilized to accomplish the proposed methodology.

Indexed as

GPC-TS-FuzzyHeart disease diagnosisInternet of things (IoT)MATLABMIT-BIH arrhythmia datasetWHO-Sigmoid-TH-NL-Demarcation

Identifiers

PMID39669140
PMCPMC11636128

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.